Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 24355310)

Published in Am J Cardiol on November 23, 2013

Authors

Waqas Qureshi1, Chetan Mittal2, Iani Patsias2, Kiran Garikapati2, Aishwarya Kuchipudi2, Gagandeep Cheema2, Mohammad Elbatta2, Zaid Alirhayim2, Fatima Khalid3

Author Affiliations

1: Section of Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Electronic address: WaqasTariq@gmail.com.
2: Department of Internal Medicine, Henry Ford Hospital/Wayne State University School of Medicine, Detroit, Michigan.
3: Section of Nephrology, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Articles citing this

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ (2015) 4.60

Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs. J Gastroenterol (2017) 1.36

Aspirin Has a Protective Effect Against Adverse Outcomes in Patients with Nonvariceal Upper Gastrointestinal Bleeding. Dig Dis Sci (2015) 0.82

Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation. Am J Med Sci (2014) 0.77

Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy. Pharmacotherapy (2015) 0.76

Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents. Ann Gastroenterol (2016) 0.75

Restarting anticoagulation after major gastrointestinal bleeding. Am J Cardiol (2014) 0.75

Emerging Tools for Stroke Prevention in Atrial Fibrillation. EBioMedicine (2016) 0.75

Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation. Am J Cardiovasc Drugs (2015) 0.75

Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry. PLoS One (2016) 0.75

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation. Stroke (2016) 0.75

Left atrial appendage occlusion for prevention of stroke in nonvalvular atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol (2015) 0.75